(S1 (S (S (PRN (-LRB- -LSB-) (NP (NP (NN Correlation)) (PP (IN between) (NP (NP (NP (NN expression)) (PP (IN of) (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor-C)) (PP (IN in) (NP (JJ tumor-associated) (NNS macrophages)))))) (CC and) (NP (NP (JJ lymphatic) (NN metastasis)) (PP (IN in) (NP (JJ oral) (NN cancer))))))) (-RRB- -RSB-))) (. .)))
(S1 (S (NP (NP (NP (NN BACKGROUND)) (NP (NNP &) (CD #38) (: ;) (NP (NN OBJECTIVE)))) (: :) (S (NP (JJ Previous) (NN study)) (VP (VBZ shows) (SBAR (IN that) (S (NP (CC both) (NP (NP (JJ vascular) (JJ endothelial) (NN growth-C)) (PRN (-LRB- -LRB-) (NP (NN VEGF-C)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ tumor-associated) (NNS macrophages)) (PRN (-LRB- -LRB-) (NP (NNS TAMs)) (-RRB- -RRB-)))) (VP (VBP are) (ADJP (JJ related) (PP (TO to) (NP (JJ lymphatic) (NN metastasis))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN study)) (VP (VBD aimed) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN correlation)) (PP (IN between) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN VEGF-C))) (PP (IN in) (NP (NP (NP (NNS TAMs)) (CC and) (NP (JJ lymphatic) (NN metastasis))) (PP (IN in) (NP (NP (JJ human) (JJ oral) (JJ squamous-cell) (NN carcinoma)) (PRN (-LRB- -LRB-) (NP (NN OSCC)) (-RRB- -RRB-)))))))))))))) (. .)))
(S1 (S (NP (NP (NNS METHODS)) (: :) (S (PP (IN After) (NP (JJ immunohistochemical) (NN staining))) (, ,) (S (NP (JJ light) (NN microscope)) (VP (VBD was) (VP (VBN used) (PP (IN for) (S (VP (VBG counting) (NP (NNS macrophages)))))))) (CC and) (S (NP (JJ automated) (NN image) (NN analysis) (NN quantification)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (JJ VEGF-C) (NN expression,which)) (VP (VBD was) (VP (VBN reflected) (PP (IN by) (NP (NP (JJ positive) (NN index)) (PRN (-LRB- -LRB-) (NP (NN PI)) (-RRB- -RRB-)))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition,the))) (NP (JJ double) (NN staining)) (VP (VBD was) (ADVP (RB also)) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (NN VEGF-C) (NN expression)) (PP (IN in) (NP (NNS TAMs)))))))))) (. .)))
(S1 (S (NP (NP (NNS RESULTS)) (: :) (S (NP (NN VEGF-C) (NN expression)) (VP (VBD was) (ADJP (ADJP (JJR higher)) (PP (IN in) (NP (NP (JJ lymphatic) (NN metastasis) (NN group)) (PRN (-LRB- -LRB-) (NP (CD PI=12.169+/-2.778)) (-RRB- -RRB-)))) (PP (IN than) (PP (IN in) (NP (NP (NN no-metastasis) (NN group)) (PRN (-LRB- -LRB-) (NP (NN PI=8.498+/-2.674)) (, ,) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (NNS TAMs) (NNS counts)) (VP (VBD was) (ADJP (JJ related) (PP (TO to) (NP (NP (JJ VEGF-C) (NN expression)) (PP (IN in) (NP (NP (NN OSCC)) (PRN (-LRB- -LRB-) (NP (NN r=0.370)) (, ,) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN result)) (PP (IN of) (NP (JJ double) (NN staining)))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (NN macrophage)) (PP (IN with) (NP (JJ positive) (NN VEGF-C) (NN expression)))) (VP (VBN accounted) (PP (IN for) (NP (NP (QP (RB about) (CD 22.8)) (NN %)) (PP (IN of) (NP (DT the) (JJ total)))))))))) (. .)))
(S1 (S (NP (NP (NN CONCLUSION)) (: :) (S (S (NP (CONJP (RB Not) (RB only)) (NP (NN tumor) (NNS cells)) (CONJP (CC but) (RB also)) (NP (NNS TAMs))) (VP (VBP secrete) (NP (NP (DT the) (NN VEGF-C)) (PP (IN in) (NP (NN OSCC)))))) (, ,) (CC and) (S (NP (NNS TAMs)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NP (JJ peritumoral) (JJ lymphatic) (NN neoangiogenesis)) (CC and) (NP (JJ lymphatic) (NN metastasis)))))))) (. .))))
